Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
44
datasets available to search
ShareScore release 0.9.0
Dataset results
44 results for “Oligoprogression”
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
ClinicalTrials.gov study NCT03808662. IPD Sharing: YES. Countries: 2. Publications: 2.
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
ClinicalTrials.gov study NCT02759835. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression
ClinicalTrials.gov study NCT04970693. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC
ClinicalTrials.gov study NCT06841172. IPD Sharing: NO. Countries: 1. Publications: 8.
Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03546829. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT04141709. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor Malignancies
ClinicalTrials.gov study NCT05846659. IPD Sharing: NO. Countries: 1. Publications: 0.
STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer
ClinicalTrials.gov study NCT06489821. IPD Sharing: NO. Countries: 0. Publications: 26.
Stereotactic Ablative Body Radiotherapy (SABR) with Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II
ClinicalTrials.gov study NCT06882499. IPD Sharing: NO. Countries: 0. Publications: 31.
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
ClinicalTrials.gov study NCT06870942. IPD Sharing: NO. Countries: 1. Publications: 0.
125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer
ClinicalTrials.gov study NCT07333651. IPD Sharing: YES. Countries: 1. Publications: 0.
Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer
ClinicalTrials.gov study NCT04838899. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
ClinicalTrials.gov study NCT06014827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
ClinicalTrials.gov study NCT05830058. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
ClinicalTrials.gov study NCT06686771. IPD Sharing: YES. Countries: 2. Publications: 0.
A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)
ClinicalTrials.gov study NCT06367972. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
ClinicalTrials.gov study NCT04299646. IPD Sharing: NO. Countries: 1. Publications: 0.
The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT07038304. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy
ClinicalTrials.gov study NCT06676722. IPD Sharing: NO. Countries: 1. Publications: 0.
SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
ClinicalTrials.gov study NCT05990192. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.